Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tellabs, Inc. (TLAB), Cisco Systems, Inc. (CSCO): Is This Telecom Networking Business a Good Pick Now?

Tellabs, Inc. (NASDAQ:TLAB) has been quite an ugly stock for investors as it has lost more than 77.7% of its value on the market over the past three years. Since the beginning of the year, it has dropped by nearly 11% to only $2 per share. I begin to notice this stock, as Joel Greenblatt began to initiate a long position in this stock in the first quarter 2013. Should we follow Joel Greenblatt into Tellabs now? Let’s find out.

Losses narrowed down but no dividend

Tellabs, Inc. (NASDAQ:TLAB)Tellabs, Inc. (NASDAQ:TLAB) is the designer and provider of various communication system products to communication service providers, including wireless and wire-line service providers, operating in four main business segments: Optical, Data, Access and Services. The majority of its revenue, $432 million, or 41% of the total 2012 revenue, was generated from the Optical segment. The Data segment ranked second with $265.5 million in revenue, while the Access and the Services segment contributed $156.5 million and $198 million, respectively, in sales in 2012. Among the four segments, Optical and Services are the two biggest profit contributors, with $89.6 million and $70 million, respectively, in operating profit, while the Data segment produced a loss of $(6.8) million.

In the first quarter 2013, it experienced a significant drop in revenue, from $257.9 million in the first quarter last year to $209.4 million in the first quarter this year, while the operating loss has been narrowed down from $(136.9) million to $(60.8) million. The improvement in the operating loss was due to much lower restructuring and other charges. The company does not employ much leverage in its operations. As of March 2013, it had more than $1 billion in total stockholders’ equity, $571.6 million in cash and investments, and around $209.6 million in loans related to other marketable securities. The company had paid dividends in the period of 2010-2012, but in the first quarter of 2013, the company does not authorize any dividend payment.

At $2 per share, Tellabs, Inc. (NASDAQ:TLAB) is worth $721.8 million on the market. Because of the huge cash on hand and little leverage, the enterprise value is much lower, at only $150.2 million. However, it does not seem to be cheap, valued at 11.2 times EV/EBITDA. Compared to its much bigger peers like Alcatel Lucent SA (ADR) (NYSE:ALU) and Cisco Systems, Inc. (NASDAQ:CSCO), Tellabs, Inc. (NASDAQ:TLAB) still seems to be relatively expensive at its current trading price.

Cisco seems to be a better and safer pick

Cisco Systems, Inc. (NASDAQ:CSCO) is the global market leader in the core router market. Along with Juniper Networks, Inc. (NYSE:JNPR), the two companies control around 80% of the total market, while Alcatel Lucent SA (ADR) (NYSE:ALU) has been trying to find its way into this market with its Extensible Routing System 7950. Its new product family was estimated to be around 66% more power efficient than the routers of its peers.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.